Literature DB >> 34036309

Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1.

Pragya D Yadav1, Gajanan N Sapkal1, Priya Abraham1, Gururaj Deshpande1, Dimpal A Nyayanit1, Deepak Y Patil1, Nivedita Gupta2, Rima R Sahay1, Anita M Shete1, Sanjay Kumar3, Samiran Panda2, Balram Bhargava2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34036309     DOI： 10.1093/cid/ciab483

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.

Authors:  Malathi Murugesan; Prasad Mathews; Hema Paul; Rajiv Karthik; Joy John Mammen; Priscilla Rupali
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

2.  SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies.

Authors:  Daniele Focosi; Marco Tuccori; Andreina Baj; Fabrizio Maggi
Journal:  Viruses       Date:  2021-06-23       Impact factor: 5.048

3.  Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers.

Authors:  Pragya D Yadav; Prasad Sarkale; Alpana Razdan; Nivedita Gupta; Dimpal A Nyayanit; Rima R Sahay; Varsha Potdar; Deepak Y Patil; Shreekant Baradkar; Abhinendra Kumar; Neeraj Aggarwal; Anita M Shete; Harmanmeet Kaur; Sreelekshmy Mohandas
Journal:  J Infect Public Health       Date:  2021-12-24       Impact factor: 3.718

4.  SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera.

Authors:  Alona Kuzmina; Seraj Wattad; Yara Khalaila; Aner Ottolenghi; Benyamin Rosental; Stanislav Engel; Elli Rosenberg; Ran Taube
Journal:  iScience       Date:  2021-11-15

5.  Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.

Authors:  Andreina Baj; Federica Novazzi; Francesca Drago Ferrante; Angelo Genoni; Elena Tettamanzi; Giuseppe Catanoso; Daniela Dalla Gasperina; Francesco Dentali; Daniele Focosi; Fabrizio Maggi
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

6.  Characteristic analysis of Omicron-included SARS-CoV-2 variants of concern.

Authors:  Hao Yang; Penghui Liu; Yong Zhang; Tingfu Du; Yanan Zhou; Shuaiyao Lu; Xiaozhong Peng
Journal:  MedComm (2020)       Date:  2022-04-09

7.  Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.

Authors:  Ramachandran Thiruvengadam; Amit Awasthi; Guruprasad Medigeshi; Sankar Bhattacharya; Shailendra Mani; Sridhar Sivasubbu; Tripti Shrivastava; Sweety Samal; Deepika Rathna Murugesan; Bapu Koundinya Desiraju; Pallavi Kshetrapal; Rajesh Pandey; Vinod Scaria; Praveen Kumar Malik; Juhi Taneja; Akshay Binayke; Tarini Vohra; Aymaan Zaheer; Deepak Rathore; Naseem Ahmad Khan; Heena Shaman; Shubbir Ahmed; Rajesh Kumar; Suprit Deshpande; Chandru Subramani; Nitya Wadhwa; Nimesh Gupta; Anil K Pandey; Jayanta Bhattacharya; Anurag Agrawal; Sudhanshu Vrati; Shinjini Bhatnagar; Pramod Kumar Garg
Journal:  Lancet Infect Dis       Date:  2021-11-25       Impact factor: 71.421

Review 8.  Facing the wrath of enigmatic mutations: a review on the emergence of severe acute respiratory syndrome coronavirus 2 variants amid coronavirus disease-19 pandemic.

Authors:  Jatin Chadha; Lavanya Khullar; Nidhi Mittal
Journal:  Environ Microbiol       Date:  2021-08-08       Impact factor: 5.476
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.